Resorcinol
CAS 108-46-3
Resorcinol (CAS 108-46-3) is a pharmaceutical compound with 9 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | Potency | 31765.5 nM | 16 | - |
| - | Ki | 15533.657692307692 nM | 13 | - |
| - | MIC | 256 ug.mL-1 | 6 | - |
| - | IC50 | 18588.155 nM | 3 | - |
| - | AC50 | 7079.5 nM | 1 | - |
| - | Kd | 86900 nM | 1 | - |
| Carbonic anhydrase 2 Enzyme |
Ki | 5.11 | - | Homo sapiens |
| Carbonic anhydrase 9 Enzyme |
Ki | 4.16 | - | Homo sapiens |
| Carbonic anhydrase 12 Enzyme |
Ki | 5.12 | - | Homo sapiens |
| Carbonic anhydrase 5A, mitochondrial Enzyme |
Ki | 5.06 | - | Homo sapiens |
| Carbonic anhydrase 5B, mitochondrial Enzyme |
Ki | 5.15 | - | Homo sapiens |
| Carbonic anhydrase 14 Enzyme |
Ki | 4.97 | - | Homo sapiens |
| Carbonic anhydrase 13 Enzyme |
Ki | 4.2 | - | Mus musculus |
| Prostaglandin G/H synthase 1 Enzyme |
Kd | 4.06 | - | Ovis aries |
| Carbonic anhydrase Enzyme |
Ki | 5.19 | - | Dicentrarchus labrax |
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| RESORCINOL | 35382 | SU | MTHSPL |
| resorcinol | 35382 | IN | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Resorcinol used for in pharmaceutical contexts?
Resorcinol (CAS 108-46-3) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Resorcinol?
No adverse-event association or SIDER side-effect rows are rendered for Resorcinol in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Resorcinol also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Resorcinol Cosmetic with EU status "restricted".
What clinical phase is Resorcinol in?
No phase 1-4 clinical development badge is rendered for Resorcinol because the matched compound identifier rows do not contain a max-phase value.
What bioactivity targets are documented for Resorcinol?
Resorcinol has 15 bioactivity rows in this page query. Rendered target entries include Carbonic anhydrase 2, Carbonic anhydrase 9, Carbonic anhydrase 12, Carbonic anhydrase 5A, mitochondrial, Carbonic anhydrase 5B, mitochondrial.